Peer insightsfrom a CLEVIPREX® (clevidipine) user
Dr. Horowitz speaks about CLEVIPREX
Renowned anesthesiologist Dr. Horowitz discusses CLEVIPREX clinical trial results and dosing in a series of informative videos for healthcare professionals.
Medical Director, Department of Anesthesiology, Delray Medical Center
CLEVIPREX Clinical Trials
Dr. Horowitz discusses efficacy and safety outcomes from pivotal trials in a variety of patient types and settings, including perioperative hypertension and acute severe hypertension.
Get an overview of how to properly administer and dose CLEVIPREX presented by Dr. Horowitz.
Connect with a KOL
Individualized, titratable administration1
CLEVIPREX offers low-volume, non–weight-based dosing that is independent of renal or hepatic function.
Proven efficacy in clinical studies1-5
CLEVIPREX provided blood pressure reduction in a range of patients and various clinical settings.
Onset within minutes1
CLEVIPREX has a titratable, fast onset of action and short half-life.